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Objective: To investigate the efficacy of carbolic acid treatment of bronchopleural fistula (BPF) using bronchofiberscope
(BFS) in post-pulmonectomy patients.
Method: Twelve patients with post-pulmonectomy BPF were enrolled in this study at the Liaoning Tumor Hospital
between February 2009 and March 2012. Three patients had BPF after the right pneumonectomy, six patients after left
pneumonectomy, one patient after the right middle and low lobectomy and two patients after left upper lobectomy.
BPF patients were instilled with 100 % carbolic acid (0.5–1 ml one time every week) through BFS on the mucosal surface
around the fistula, and the bubble disappearance was monitored. Treatment was repeated if the bubble remained.
Results: No haemorrhage, severe dyspnea or SpO2 declines occurred in all the 12 patients during the bronchoscopic
therapy. BPF orifices were closed in five patients after receiving 5 treatments with carbolic acid, 1 patient received 2
treatments, 1 patient was given 3 treatments, 2 patients received 4 treatments and 3 patients were given 7 treatments.
Follow-up was conducted for six months following bronchoscopy. The average treatment and fistula closure time were
calculated from the data collected as 20 min and 30 days, respectively, and the cure rate was 100 %. Hematoxylin-eosin
(HE) staining results revealed that the white flat hyperplasia tissue after carbolic acid treatment was inflammatory
granulation tissue.
Conclusion: Our results revealed that instillation of 100 % carbolic acid with BFS to treat BPF was 100 % effective, which
can be a support for post-pulmonectomy BPF.
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Bronchopleural fistula (BPF) is a relatively infrequent but
potentially fatal complication of pulmonary resection. BPF
can be divided into peripheral or central, based on the lo-
cation of the leakage, and BPF occurs in about 1.5 to 28 %
of pneumonectomy cases, and is associated with high
death rate [9, 30]. It is estimated that incidence of BPF
after pneumonectomy and lobectomy for lung cancer is
4.5–20 % and 0.5 %, respectively, and the incidence of BPF
is highest after right pulmonary resection and right lower
lobectomy [31]. The etiology of BPF includes incomplete* Correspondence: wangzhengwz822@163.com
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and prolonged postoperative mechanical ventilation as
major risk factors of BPF [31]. The clinical manifestations
of BPF can be frequently classified as acute, subacute, and
chronic. An acute BPF presents as tension pneumothorax,
with pleural cavity communicating abnormally with the
airways, and is associated with purulent sputum expector-
ation, dyspnea, and reduction in established pleural effu-
sion [22]. The presentations of subacute and chronic BPF
are commonly related to a pleural space with infection,
manifesting as a more invisible form with fever, dry cough,
and malaise with different levels of respiratory disorder
[33]. Traditional treatments of BPF include thoracotomy
after drainage and primary repair, which is based onis distributed under the terms of the Creative Commons Attribution 4.0
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[20]. Amplatzer vascular plug, which was originally de-
signed for the transcatheter closure of vascular structures,
has also been reported as a safe and effective method to
treat small postoperative BPF [9]. Fruchter et al. also
found that the technique of Amplatzer double-disk occlu-
der implantation may be suitable for both large and small
BPFs which originate from the main bronchi and lobar
bronchi, respectively [8]. Additionally, endoscopic ap-
proaches and bronchoscopy are common methods of
treating BPF to avoid thoracotomy [27, 36].
Bronchofiberscope (BFS) is a precision instrument
employed to diagnose bronchial diseases using of the
light guide composed by the fine fibers formed by tens
of thousands of high transmittance glass or acrylic resin
[12, 16]. BFS is designed to offer advantageous features
such as easy operation method, clear vision, mild
trauma, tolerance of surgery by patients, and high safety
profile, which reduces or avoids complications associated
with tracheotomy and prevents local infection [25, 32].
Clinically, BFS has multiple uses, including removing
foreign bodies, eliminating secretions, treating naso-
pharyngeal carcinoma, central lung cancer, alveolar cell
carcinoma, esophageal fistula, hemoptysis, obstruction,
assisting endotracheal intubation treatment and placing
gastric tube [1, 11, 21]. Previous studies have revealed
that BFS is also an excellent diagnostic tool for early
detection of various intrabronchial injuries, and the at-
tached biopsy sampling feature is helpful in the identifi-
cation of early lesions, and to carry out poly excision
surgery for the studies on bronchus and lung diseases
[15, 18, 19]. Previous studies reported various treatment
methods for BPF using BFS, and the methods include
gelfoam, shot put plugs, and tissue adhesives. However,
these methods have significant deficiencies, evident
from the fact that treatment fistula under 3 mm was ef-
ficient using these methods, but they show poor efficacy
in treatment of BPF beyond 3 mm, particularly those
beyond 10 mm [6, 28, 35, 37]. Phenol, also named car-
bolic acid, is a sweet-smelling colorless liquid used to
prepare resins, preservatives, fungicides, drugs (e.g., as-
pirin), and also is used to disinfect surgical instruments
[4, 24, 38]. 88 % carbolic acid was found to be effica-
cious with all alopecia areata patients and can be con-
sidered as a treatment of choice for stable alopecia
areata [3]. Moreover, spot peel with 88 % phenol can be
a cost-effective procedure for idiopathic guttate hypo-
melanosis, which can be combined with other medical
therapies [26].
There are no studies using carbolic acid to treat BPF
with the help of BFS at present. Therefore, we investi-
gated the efficiency of carbolic acid treatment of BPF in
post-pulmonectomy patients, by instilled 100 % carbolic
acid with the aid of BFS.Methods
Ethics statement
This study was conducted with the approval of the
Institutional Review Board of Liaoning Tumor Hospital,
Shenyang. The informed written consent was collected
from each eligible patient and the whole study was per-
formed based on the Declaration of Helsinki [14].
Study population
A total of 12 patients with post-pulmonectomy BPF were
enrolled at the Department of Thoracic Surgery, Liaoning
Tumor Hospital, Shenyang between February 2009 and
March 2012. Orificium fistulae were confirmed by bron-
choscope and the average diameter was 4.5 mm. The eli-
gible patients included eight males and three females, with
an average age of 56 years (range, 45 ~ 71 years). Three
patients had BPF after the right pneumonectomy, six after
the left pneumonectomy, one after the right middle and
low lobectomy and two after left upper lobectomy.
Preoperotive preparation
Electrocardiogram, routine blood tests and biochemical
examination were performed in all the patients. Patients
were fasted for 4 ~ 6 h in preparation for surgery and
received 10 mg diazepam and 1 mg atropine via intra-
muscular injection about 30 min before operation. In
addition, 1 % lidocaine was used for nasopharyngeal
anesthesia by nebulizer.
Intraoperative methods
All patients were instructed to take supine position ex-
cept 2 patients with short breath in sitting position. The
BFS (Olympus BF1T40) was inserted into the trachea
through nasal cavity. Heart rate, blood pressure and
SpO2 was monitored. Patients received local nasopha-
ryngeal anesthesia with 2 % lidocaine to alleviate irritant
reaction. The bronchus around the suture was bubbling
when the patient breathed deeply. The fistula was ob-
served via BFS. After the drainage of secretion, he-
matocele or pus around the BPF, a bronchoscopy biopsy
forceps was used for removing necrotic tissues and a
1.8 mm flexible tube was guided through the biopsy
hole. The distal end of BFS was brought out and fixed
0.3 cm above the fistula. With breath holding, 100 %
carbolic acid solution (0.5–1.0 ml) was instilled to bron-
chial mucosa through the BFS. The bronchial mucosa
became pale after treatment and finally the flexible tube
and bronchoscope were removed.
Postoperative and histological observation
After the surgery, the patients were treated with closed
drainage of thoracic cavity, anti-inflammatory, symptom-
atic and supportive treatments. Gas discharge in thoracic
drainage tube was observed, and fistula healing were
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was gas discharge from thoracic drainage tube, or further
observations were made. Patients could leave hospital
after blood routine test showing no evidence of dyspnea,
fever, positive culture of fluid drainage (3 times). Paraffin
sections (4 ~ 6 μm) of bronchial stump were stained by
hematoxylin and eosin (HE) to observe the irritation of
bronchial stump after instilled with carbolic acid solution.
Results
Outcome characteristics of BPF
In the 12 patients with BPF, the median diameter of the
BPF orifice was 4.5 mm, according to the intraoperative ob-
servation. Specifically, 3 patients showed a fistula diameter
of 3 mm or smaller, 6 patients showed a fistula diameter
of 3 ~ 5 mm, and 3 patients exhibited a fistula diameter of
5 mm or larger, 1 of whom had a fistula diameter of 7 mm
(Table 1). Serious complications, such as haemorrhage, se-
vere dyspnea and SpO2 declines, did not occur in all the
12 patients during bronchoscopic therapy. Of note, BPF
orifices in 5 patients closed after 5 treatments with car-
bolic acid, 1 patient through 2 treatments, 1 patient
through 3 treatments, 2 patients through 4 treatments
and 3 patients through 7 treatments (Fig. 1). Follow-up
was conducted for six months after bronchoscopy. Based
on the data collected, the average treatment time of the 12
patients was calculated as 20 min and the average time of
fistula closure was 30 days. Importantly, the cure rate was
100 %.
HE staining
HE staining was performed to observe bronchial stumps
stimulated by carbolic acid infusion. The biopsy showed
that the white flat hyperplasia tissue (bronchial stumpsTable 1 Characteristics and outcomes of BPF patients
Age(y) Gender Initial symptom Surgical method
1 48 male Low fever Right PNY
2 56 male High fever Right PNY
3 50 male Blood sputum Left PNY
4 71 male Irritating cough Left upper LBY
5 57 female Low fever Right upper LBY
6 65 male Fever/air bubble Left PNY
7 64 male Cough/fever Left PNY
8 59 male Cough/fever Right PNY
9 62 male Low fever Left upper LBY
10 58 male Fever/sputum Left PNY
11 45 male Low fever Left PNY
12 56 male sputum Left PNY
BPF bronchopleural fistula, y years, PNY pneumonectomy, LBY lobectomy, d daystissue) after carbolic acid treatment was inflammatory
granulation tissue. Furthermore, it was found that the
tissue was loose and dropsical, with a small amount of
proliferation of irregularly distributed fibroblast, small
vascular proliferation, a large number of plasma cells
and lymphocyte infiltration, and a small amount of
irregularly arranged squamous epithelial hyperplasia, as
shown in Fig. 2.
Discussion
BPF is defined as an abnormal communication between
a lobar or the main bronchus and the pleural space, and
continues to be a severe surgery complication, which is
related to high morbidity and mortality [13]. Risk factors
associated with BPF incidence are fever, steroid use,
anemia, leukocytosis and tracheostomy, elevated eryth-
rocyte sedimentation rate, Haemophilus influenzae in
sputum and bronchoscopy for sputum suction or mucus
plugging [2]. Recently, a number of flexible broncho-
scopic techniques have been used to seal BPFs. These
materials include cyanoacrylate-based glues, absorbable
gelatine sponge, vascular embolisation devices, and fibrin
compounds [7, 10]. In this study, we describe a novel ap-
proach of using carbolic acid for the closure of fistulas.
Carbolic acid has a strong reaction with mucosal tissues,
and pure carbolic acid corrodes mucosa completely in
60 s. When carbolic acid contacts the mucosal surface,
the mucosa tissues is rapidly degenerated (pale), and
mucosal inflammation stimulate exudation and proli-
feration, finally resulting in the closure of fistula [34].
Carbolic acid is widely used for disinfecting appendi-
ceal stump in appendicitis operation and in the treat-
ment of suspected TB contaminants in tuberculosis
surgery [5, 17].Bronchopleural fistulae
Size (mm) Treatment times Cure time (d) Follow up
3 5 35 alive
3.5 5 35 alive
1 3 21 alive
1.5 4 28 alive
4 5 35 alive
5 7 49 unknown
7 7 49 alive
1 2 14 alive
4 7 49 alive
5 5 35 alive
3.5 4 28 alive
4 5 35 alive
Fig. 1 The treatment process of carbolic acid: a the BPF (about 1 mm); b infused by the carbolic acid; c BPF narrowed after 2 times instillation, and
bubbles appeared after carbolic acid infused with saline; d repositioned the fistula, and three times later the BPF healed. Note: BPF, bronchopleural fistula
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100 % carbolic acid through BFS in the treatment of
BPF. The 12 patients treated with carbolic acid success-
fully reached fistula closure, with the total effective rate
at 100 % without any adverse reactions of hemoptysis
and dyspnea. A reasonable explanation might be that
carbolic acid is relatively safe, a small amount of acid
liquid overflow will not cause serious injuries to normal
mucosal [29]. A number of advantages are embodied in
the instillation of carbolic acid under BFS. First, this
method is easy to perform and, based on it success rate
in this study, likely to be readily accepted by theFig. 2 Results of HE staining observing bronchial stumps tissues
stimulated by carbolic acid infusion. Note: HE, hematoxylin and eosinpatients, and patient hospitalization is unnecessary if
they are in good condition. Second, for patients who
have larger fistula with significant pleural effusion and
sputum, this therapeutic tool can rapidly relieve the
symptoms and avoid aspiration pneumonia. Third, the
fistula location, size, shape can be clearly orientated. Fi-
nally, it can help reduce operative risks, decrease mortal-
ity rate as well as the cost of treatment for BPF [13].
Our results also revealed that the healing time of fistula is
positively correlated to its size. Based on the clinical ob-
servations of series of cases, we summarize that fistula <
5 mm healed in much shorter time compared to fistula ≥
5 mm. However, if the size of fistula exceeded certain
limit, it might be difficult to heal due to the potential
lack of healthy mucosa to stimulate proliferation and
regenerate tissue [23].
Our study presents clear evidence that use of carbolic
acid for BPF treatment under the inspection of BFS is
safe and 100 % effective. However, our findings need to
be interpreted with caution due to limitations in the
study. A limitation is the small number of patients with
BPF who underwent BFS. Therefore, our study con-
tained a relatively smaller sample size, which might
restrict the application of our results to a wider popula-
tion. Further studies using large sample size and better
study designs will be necessary to confirm our findings.
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In conclusion, we achieved 100 % efficacy in treat-
ment of BPF with carbonic acid through BFS, with
BPF size ranging from 3–7 mm in diameter. The de-
scribed procedure is simple, safe and an effective
choice for BPF patients, with little pain and at rela-
tively low cost.
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